CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to evaluate the safety and efficacy of abenacianine for injection, a tumor-targeted, activatable fluorescent imaging agent, to identify cancer...
Phase 3
Duarte, California, United States and 5 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Los Angeles, California, United States and 90 other locations
The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.
Phase 1
Los Angeles, California, United States and 30 other locations
the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...
Phase 1, Phase 2
Los Angeles, California, United States and 9 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Los Angeles, California, United States and 210 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Los Angeles, California, United States and 123 other locations
locally advanced or metastatic disease.In addition, HER3-DXd will be evaluated in participants with locally advanced or metastatic NSCLC whose tumors...
Phase 1
Duarte, California, United States and 36 other locations
HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...
Phase 1
Los Angeles, California, United States and 21 other locations
This is a Phase II, multi-site, open-label, parallel group study in participants with untreated extended-stage small-cell lung cancer...
Phase 2
Los Angeles, California, United States of America and 64 other locations
This study evaluates a fenretinide phospholipid suspension for the treatment of small cell lung cancer (SCLC)....
Phase 1
Los Angles, California, United States
Clinical trials
Research sites
Resources
Legal